| Feature
Article |
 |
Algae
Agonist
Algae
blooms are suffocating the Chesapeake Bay. Richmond’s Infilco
Degremont is perfecting biological
filters that remove the
nutrients the noxious organisms feed
upon.
In
the summer of 2003, one of the
largest “dead zones” on record
covered 40 percent of the
Chesapeake
Bay.
Massive blooms of algae – some
mahogany red, some as
green as Gatorade -- blotted the
surface, then died and sank to the
bay floor. The decaying mass fed a
host of microorganisms that sucked
most of the oxygen from the water.
Throughout the zone, oxygen fell
below the level required to keep
striped bass alive. In places, the
oxygen depletion was so severe that
shad, yellow perch, crabs and
oysters died off. In the worst
spots, only worms and other
low-metabolism creatures could
survive.
The
algae feed off nitrogen and
phosphorous from farms, urban
run-off, air pollution and, most
visibly, wastewater treatment plants. To
combat the decline of what once was
one of the most bountiful estuaries
in the world, Virginia and other
states in the Chesapeake Bay
watershed committed four years ago
to reduce the volume of nitrogen
entering the bay and its tributaries
by 110 million pounds per year, or
nearly 40 percent, by 2010. A set of
tighter rules, wending its way
through the regulatory system,
should go into effect in late 2005
or early 2006.
Fairly
or not, much of the clean-up burden
will fall upon wastewater
treatment plants that are a major
source of the nutrients. The
potential cost of retrofitting or
building some 300 treatment plants
could run into the billions of
dollars, and the race is on to develop a
technology that allows
municipalities to meet the standards
without crippling them financially.
A
Richmond,
Virginia,
company, Infilco Degremont, may have
the most cost-effective answer: a
process that uses naturally
occurring bacteria to ingest the
nutrients as the water flows past.
Robert
Kelly, director of Infilco
Degremont’s R&D lab in
downtown Richmond,
says he knows of only one competing
technology that can reliably meet the
proposed standard of three
milligrams of nitrogen per liter of
water. But he believes his product,
BIOFOR, has an edge. Because BIORFOR
installations operate more
efficiently at higher filtration
rates, they don't take up
as much space – a crucial
consideration for existing water
treatment facilities that typically
have little free room for expansion.
Water
treatment doesn’t capture the
public’s imagination like gene
splicing or nano-tech, but it is a
multibillion-dollar business with
global reach. There are only a
handful of players pushing the
envelope of new technology, one them
being the $43 billion-a-year
Suez
group, the French conglomerate that
owns Infilco Degremont. Degremont maintains two water research
centers: one in Paris
and one in Richmond.
“Our mission,” says Kelly, “is
to innovate new technologies for
drinking water and wastewater
treatment.”
The
13-person
Richmond
lab, supplemented periodically by
college interns, takes the corporate
lead on R&D related to the
biological filtration for removal of
nutrients such as nitrogen
and phosphates, ultraviolet
disinfection of microbes, and
micro-bubble flotation to separate
minute solids from liquids. Through Degremont’s globe-spanning
operations, innovations originating
in Richmond migrate around the world.
Infilco Degremont originated as the International Filter
Company of Chicago
in 1894. Acquired by Paris-based
Degremont in 1974, the main quarters
of the U.S.
affiliate now are located in the
west end of Richmond.
Earlier this year, the American
operation changed its name from
Ondeo Degremont to Infilco Degremont
in recognition of its strong U.S.
water treatment equipment heritage.
The
Richmond
operation designs, engineers,
manufactures and provides services
to municipal and industrial water
treatment systems. Solutions
encompass both chemical-physical
treatment and biological systems.
Says Ilan Wilf, vice president of
sales and marketing: “We are known
across the U.S.
for our emerging technologies,
engineering excellence, and
customer-driven solutions.”
The
Degremont Group’s European
operations are more oriented toward
DBO, or the “design, build and
operate” end of the business. The
focus there is mainly on new plants.
The U.S.
affiliate is more geared to
providing engineering services and
developing new products. Serving
markets around the world, the
company has a major presence in the Middle
East.
In the 1970s and 1980s, the company
installed more water and wastewater
facilities in Iraq than any other
country, and it remained engaged in
that troubled country as part of the
United Nations-sponsored
Oil-for-Food program.
The
Richmond R&D operation operation
– known as Denard, for Degremont
North
American
R&D
Center
– plays a key role in fulfilling
Infilco’s global corporate
strategy. The lab analyzes drinking
water and wastewater quality as a service to
customers, works with the commercial
side of the business to set up pilot
plants to demonstrate the efficacy
of new technologies and, of course,
continually refines water treatment
technologies.
Located
in the Virginia
Biotechnology
Research
Park,
the Infilco R&D lab belongs to a
growing cluster of life-sciences
research operations in the Richmond
region. In the research park itself are
the corporate R&D facilities of
Boehringer Ingelheim
Pharmaceuticals, Science
Applications International Corp.,
and the United Network for Organ
Sharing (UNOS).
Adjacent to the medical campus of
Virginia Commonwealth
University,
the park houses more than 50
biosciences companies employing more
than 1,350 people in fields such as
drug development, medical
diagnostics, biomedical engineering,
forensics and environmental
analysis. This vibrant mix of
life sciences companies, combined
with the proximity of VCU and
Richmond’s low cost of doing
business, says Robert Skunda, CEO of
the research park, has contributed
to Richmond’s emergence as a
recognized player in the life
sciences arena.
“We’re really impressed with Denard’s research
on de-nitrification,” says Renee
Robins, vice president-business
development for the Greater Richmond
Partnership, the region’s economic
development organization. “First
of all, it addresses one of the most
pressing environmental issues we
face in Virginia,
the eutrophication of the Chesapeake Bay."
But equally exciting, Robins says, is the potential
to create a technology with global
applications. Dead zones are killing
fish, shell fish and crustaceans in
rivers and estuaries on every
continent, destroying a vital source
of seafood. “By making it
affordable to take the nitrogen and
phosphorous out of waste water,
Infilco and Denard can make life
better for millions of people around
the world.”
Infilco
calls its biological filtration
technology BIOFOR. Conceptually, the
process is simple. Biological
filtration is one of the final steps in the
wastewater treatment process, coming
into play after conventional
techniques have already removed
contaminants visible to the naked
eye. Microbes consume the nitrogen-bearing compounds in the water,
metabolize them, and ultimately release
harmless nitrogen gas into the
atmosphere.
The devil is in the details.
Waste
water is pumped through a large,
vertical cell filled with a
“support matrix,” jargon for
finely crushed rock to which the
bacteria adheres and the water
passes through. Pebble-sized rock of
varying specifications support different
types of bacterial populations. The
selection of the proper growth
medium is crucial. Right now,
Infilco has to import much of the support
matrix, a type of expanded clay or shale,
all the way from Europe.
“We’re paying to ship rocks
across the ocean,” notes Kelly
wryly. His team is looking for
alternative U.S. suppliers to
improve the cost efficacy of the
technology.
Depending on the type of microbial populatoin desired, Infilco tweaks
other variables such as water
temperature, the oxygen level, the rate
of water flow through the filter
cell, and
the frequency with which the
build-up of bacterial biomass is
removed through backwash. Says Kelly: “The idea is
to provide growth conditions that
allow a select group of
[nitrogen-eating] organisms to
out-compete other organisms."
In most cases, says Kelly, the biological filters are
naturally seeded – the filters
host bacteria naturally found in the
waste water. No genetically modified
monster microbes here. Occasionally,
Infilco jump starts bacterial growth
with freeze-dried organisms.
Operating
in more than 100 installations
globally, BIOFOR technology is a
well-established wastewater
treatment process. Infilco now is testing its latest refinement, the BIOFOR DN
technology, at
a treatment facility in New Rochelle,
N.Y.,
with the goal of meeting the three
milligrams-per-liter standard. This
pilot
project, lasting six months to a
year, is the first step in moving
the BioFor process from the lab into
the real world, Kelly says. Once the
plant demonstrates that it can meet
the strict new standard, BIOFOR DN
will be ready for prime time.
Meanwhile, Infilco is fine tuning a
phosphorous removal
technology that uses dissolved air
flotation in a test at
Chesterfield
County’s
Proctor’s Creek plant. The concept
is an old one, but Degremont's
design allows it to operate at
six to ten times the rate of
convention designs, allowing
it to be installed on a much smaller
footprint, Kelly explains.
When it comes to cleaning up the Bay, says Chuck Epes,
communications coordinator for the
Chesapeake Bay Foundation,
“Nitrogen is the 800-pound
gorilla.” Phosphates, he adds, are
“a 300-pound gorilla.” He’s
unfamiliar with Infilco’s NIOFOR
process, so he can’t comment on
it. But, given the regulations
coming down the pike, he says, any
technology that helps municipalities
and manufacturers meet the impending
regulations at lower cost “is
certainly welcome news."
--
September 2004
|